via National Human Genome Research Institute
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has the potential to protect us against serious life-limiting diseases such as cancer and dementia
Researchers from the University of Sheffield have discovered a new gene therapy pathway that has uncovered an important regulatory mechanism to keep our genome healthy. This pathway has the potential to protect us against serious life-limiting diseases such as cancer and dementia.
Cancer and neurodegeneration are two major health challenges currently affecting the population, and they constitute two sides of the same coin – one is caused by uncontrolled cell proliferation due to genome damage, and the other is caused by excessive genome damage that causes cell death. This new pathway impacts both and offers new therapeutic opportunities to help the fight against disease.
Published in Nature Communications, the research found that when cells in our body read DNA to build proteins, they often make mistakes that can damage our genome, causing disease such as cancer and dementia. However, by investigating how cells fix damage in the DNA to keep us healthy, scientists have discovered the benefits of three proteins working together as a team. The three proteins, called USP11, KEAP1 and SETX, receive instructions from their coach to direct their function in space and time with remarkable harmony, to keep our DNA healthy.
By understanding how cells protect themselves from these mistakes and thus preventing diseases, scientists are able to modify the behaviour of these proteins to promote the health and wellbeing of people.
Findings from this study will enable scientists to develop diagnostic tests and drugs to target one or more of the proteins in the pathway for the early detection and treatment of certain types of cancer and neurological disease. Developing new drugs to regulate the level of one or more of these proteins is expected to offer new treatments for cancer and dementia.
The findings are important and significant, this is because we are now at the stage where we could make drugs to control this modification. This would be useful in killing cells, which is what we do when we treat elderly people for cancer. The other application would be to reduce the level of genome damage, which could be beneficial for other ageing associated disorders like dementia.
Original Article: New gene therapy pathway could protect us from cancer and dementia
More from: University of Sheffield
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy pathway
- Global Cell and Gene Therapy in Ophthalmology Research Report 2024: Market Anticipated to Soar with Projected CAGR Growth of 50.8% by 2029on May 9, 2024 at 2:43 am
With the FDA offering specific guidance for gene therapy applications in retinal disorders, the pathway for bringing new treatments to market is further delineated. This structured regulatory ...
- Sarepta Seeks Label Expansion, Bigger Market for DMD Gene Therapyon May 8, 2024 at 7:00 am
As Sarepta Therapeutics moves closer to full approval and an expanded label for its gene therapy, some experts push back on clinical efficacy and cost while others note the hope it provides patients ...
- Mass General Brigham Gene and Cell Therapy researchers present key findings at ASGCTon May 6, 2024 at 4:59 pm
Leaders and investigators from the Mass General Brigham Gene and Cell Therapy Institute, a hub of innovation dedicated to accelerating groundbreaking research, conducting clinical trials and ...
- FDA’s Accelerated Approval of Sarepta DMD Gene Therapy Comes Under Fireon May 3, 2024 at 6:21 am
Ahead of the FDA’s June target action date for Sarepta’s Duchenne muscular dystrophy gene therapy, ICER Chief Medical Officer David Rind blasted the regulator’s accelerated pathway in a JAMA viewpoint ...
- Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per doseon April 26, 2024 at 3:18 am
It becomes the first FDA-approved gene therapy for Pfizer and the second ... The company also is testing an anti-tissue factor pathway inhibitor to treat people with hemophilia A and B.
Go deeper with Google Headlines on:
Gene therapy pathway
[google_news title=”” keyword=”gene therapy pathway” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Gene therapy
- Global Cancer Gene Therapy Market Expected to Grow at 10.1% CAGR, Reaching USD 5.3 Billion by 2032on May 12, 2024 at 6:12 pm
The global cancer gene therapy market is poised for significant growth, projected to surge at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2032. According to Future Market Insights (FMI) ...
- Gene therapy provision would make life-saving treatment more accessible and equitableon May 12, 2024 at 3:00 pm
A conference committee at the Minnesota Legislature will decide whether to include the coverage provision in the final version of the bill.
- Baby born deaf hears after unique gene therapyon May 12, 2024 at 9:33 am
Opal Sandy, now 18 months old, was completely deaf at birth due to a rare genetic condition called auditory neuropathy. But within four weeks of receiving a gene therapy infusion in her right ear as ...
- More children gain hearing as gene therapy for profound deafness advanceson May 10, 2024 at 3:08 pm
Enlarge / Opal Sandy (center), who was born completely deaf because of a rare genetic condition, can now hear unaided for the first time after receiving gene therapy at 11-months-old. She is shown ...
- Toddler born deaf can hear after gene therapy trial breakthrough her parents call "mind-blowing"on May 10, 2024 at 1:34 pm
The parents of a U.K. toddler say it's "absolutely mind-blowing" to see their daughter, enrolled in a gene therapy trial, hear for the first time.
Go deeper with Google Headlines on:
Gene therapy
[google_news title=”” keyword=”gene therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]